Similar companies
Income Statement (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Gross Profit | -5.2M | 36.3% |
| Cost of Revenue | 5.2M | 30.1% |
| Operating expense | 17M | 3.2% |
| Net Income | -14M | 5.9% |
| EBITDA | -13M | 5.7% |
Balance Sheet (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Total Assets | 267M | 2.4% |
| Total Liabilities | 37M | 19.6% |
| Total Equity | 230M | 5.2% |
| Shares Outstanding | 44M | 0.1% |
Cash Flow (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Cash from operations | -7.2M | 49.3% |
| Cash from investing | -2,000 | 98.9% |
| Cash from financing | 51,000 | 100% |
EPS
Financial Highlights for enGenes in Q3 '24
Gross Profit stood at -5.2M, marking a 36.3% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 5.2M, a -30.1% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 17M, showing a -3.2% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -14M, showing a 5.9% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -13M, showing a 5.7% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
The company's performance remained stable this quarter with no significant positive or negative changes in the key financial metrics.
